Deciduous Therapeutics Funding & Investors

Deciduous is developing a novel class of immune-modulatory therapies designed to promote a healthy lifespan.

deciduoustx.com

Total Amount Raised: $16,500,000

Deciduous Therapeutics Funding Rounds

Seed
$10,000,000
Dec 30, 2022
Seed Investors
Bold Capital Partners
Humboldt Fund
Owl Capital
Healthspan Capital
Seed
$6,500,000
Jun 27, 2019
Seed Investors
CRV (Charles River Ventures)
8VC
Presight Capital
The Longevity Fund

Funding info provided by Diffbot.